- Home
- JKHY vs FMS Comparison
JKHY vs FMS Comparison
Compare JKHY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKHY | FMS |
|---|---|---|
| Founded | 1976 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 14.2B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | JKHY | FMS |
|---|---|---|
| Price | $157.07 | $22.42 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 12 | 2 |
| Target Price | ★ $197.25 | $30.00 |
| AVG Volume (30 Days) | ★ 784.8K | 420.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | 1.55% | ★ 2.54% |
| EPS Growth | ★ 19.31 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | ★ $1,536,603,000.00 | N/A |
| Revenue This Year | $8.03 | $0.45 |
| Revenue Next Year | $6.35 | $3.76 |
| P/E Ratio | $42.51 | ★ $15.62 |
| Revenue Growth | ★ 7.37 | N/A |
| 52 Week Low | $144.13 | $20.96 |
| 52 Week High | $193.39 | $30.46 |
Technical Indicators
Market Signals| Indicator | JKHY | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 46.50 |
| Support Level | $155.58 | $21.56 |
| Resistance Level | $158.99 | $24.08 |
| Average True Range (ATR) | 4.18 | 0.36 |
| MACD | -0.51 | 0.04 |
| Stochastic Oscillator | 28.21 | 47.25 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.